Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Dairy Sci ; 103(5): 4588-4605, 2020 May.
Article in English | MEDLINE | ID: mdl-32113759

ABSTRACT

Staphylococcus aureus is one of the pathogens most frequently isolated from cases of mastitis worldwide. To decrease the effect of S. aureus mastitis in dairy farming, alternative strategies for controlling mastitis are needed that depend on a better knowledge of cow-to-cow variations in S. aureus antibody production. The present study sought to explore the diversity of S. aureus antibodies produced by dairy cows with a distinct mastitis history and vaccinated with a polyvalent mastitis vaccine. We obtained protein extracts from S. aureus isolates derived from persistent subclinical mastitis. Proteins were fractionated using 2-dimensional gel electrophoresis and Western blotting. Then, Western blotting membranes were exposed to sera from 24 dairy cows that had been divided into the following groups: vaccinated dairy cows that were infected with S. aureus, further subdivided according to whether they (a) remained infected by S. aureus or (b) recovered from the intramammary infection; unvaccinated dairy cows infected with S. aureus; and vaccinated healthy dairy cows with no history of S. aureus mastitis. Proteins found to be reactive by Western blot were identified by mass spectrometry (MALDI/TOF-TOF). Our most important finding was that F0F1 ATP synthase subunit α, succinyl-diaminopimelate desuccinylase, and cysteinyl-tRNA synthetase were potential candidate proteins for the prevention of S. aureus mastitis. This study strengthens the notion that variations among animals should not be ignored and shows that the heterogeneity of antibody production against anti-staphylococcal antigens in animals may enable the identification of new immunotherapy targets.


Subject(s)
Antibodies, Bacterial/blood , Mastitis, Bovine/immunology , Staphylococcal Infections/veterinary , Staphylococcal Vaccines/administration & dosage , Staphylococcus aureus/immunology , Animals , Antibodies, Bacterial/immunology , Cattle , Female , Humans , Mastitis, Bovine/microbiology , Mastitis, Bovine/prevention & control , Milk , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Staphylococcal Vaccines/immunology
2.
Parasite Immunol ; 35(7-8): 239-44, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23668415

ABSTRACT

Previously, we showed in Leishmania infections that extrinsic insulin-like growth factor (IGF)-I favored Leishmania proliferation and leishmaniasis development. In this study, the interaction of intrinsically expressed IGF-I and Leishmania (Leishmania) major in macrophages was addressed, and a key finding was the observation, using confocal microscopy, of the co-localization of IGF-I and parasites within macrophages. Following stimulation with interferon-γ (IFN-γ), which is known to inhibit IGF-I production in macrophages, we observed a reduction in the expression of both IGF-I mRNA and protein. This reduced expression was accompanied by a reduction in the cellular parasite load that was completely recovered with the addition of extrinsic IGF-I, which suggests an essential role for IGF-I in Leishmania growth.


Subject(s)
Insulin-Like Growth Factor I/metabolism , Leishmania major/growth & development , Macrophages/metabolism , Macrophages/parasitology , Animals , Cell Line, Tumor , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/pharmacology , Interferon-gamma/immunology , Leishmania major/metabolism , Mice , Microscopy, Confocal , Parasite Load , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...